60 related articles for article (PubMed ID: 7522355)
1. Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind study.
Samama CM; Mazoyer E; Bruneval P; Ciostek P; Bonnin P; Bonneau M; Roussi J; Bailliart O; Pignaud G; Viars P
Thromb Haemost; 1994 May; 71(5):663-9. PubMed ID: 7522355
[TBL] [Abstract][Full Text] [Related]
2. Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig.
Samama CM; Bonnin P; Bonneau M; Pignaud G; Mazoyer E; Bailliart O; Maffrand JP; Viars P; Caen JP; Drouet LO
Thromb Haemost; 1992 Nov; 68(5):500-5. PubMed ID: 1455394
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding.
Charbonneau S; Girard F; Boudreault D; Ruel M; Blais N; Hardy JF
Thromb Haemost; 2007 Feb; 97(2):296-303. PubMed ID: 17264960
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel use for reducing the rate of thrombosis in a rat model of microarterial anastomosis.
Nayak VK; Deschler DG
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):800-3. PubMed ID: 16172359
[TBL] [Abstract][Full Text] [Related]
5. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of aprotinin in arterial switch operations in infants.
Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K
Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis.
Khan TA; Bianchi C; Voisine P; Sandmeyer J; Feng J; Sellke FW
Ann Thorac Surg; 2005 May; 79(5):1545-50. PubMed ID: 15854931
[TBL] [Abstract][Full Text] [Related]
10. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A
Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
[TBL] [Abstract][Full Text] [Related]
11. Anesthetic technique does not affect the performance of a rabbit model of arterial cyclic flow reductions: a pilot study.
Charbonneau S; Girard F; Boudreault D; Ruel M; Hardy JF
Can J Anaesth; 2007 Apr; 54(4):269-75. PubMed ID: 17400978
[TBL] [Abstract][Full Text] [Related]
12. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
13. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
Li CJ; Huang J; Yang ZJ; Cao KJ
Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
Ward KR; Tiba MH; Holbert WH; Blocher CR; Draucker GT; Proffitt EK; Bowlin GL; Ivatury RR; Diegelmann RF
J Trauma; 2007 Aug; 63(2):276-83; discussion 283-4. PubMed ID: 17693824
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model.
Godier A; Durand M; Emmerich J; Dizier B; Lecompte T; Samama CM
Thromb Haemost; 2011 Jan; 105(1):161-8. PubMed ID: 20941458
[TBL] [Abstract][Full Text] [Related]
19. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
20. Medical haemostasis in acute hepatocyte injury and experimental liver trauma.
Cihan A; Yilmaz E; Yenidünya S; Uçan BH
ANZ J Surg; 2005 Apr; 75(4):239-43. PubMed ID: 15839974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
